ES2159938T3 - Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona. - Google Patents
Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona.Info
- Publication number
- ES2159938T3 ES2159938T3 ES98908080T ES98908080T ES2159938T3 ES 2159938 T3 ES2159938 T3 ES 2159938T3 ES 98908080 T ES98908080 T ES 98908080T ES 98908080 T ES98908080 T ES 98908080T ES 2159938 T3 ES2159938 T3 ES 2159938T3
- Authority
- ES
- Spain
- Prior art keywords
- oral
- methyl
- decaprenil
- benzoquinona
- dimetoxi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Botany (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Preparado transdérmico, oral o intravenoso de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona que contiene, además de coadyuvantes usuales, una cantidad eficaz de tensioactivo pulmonar.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19705231 | 1997-02-11 | ||
CA002280316A CA2280316A1 (en) | 1997-02-11 | 1999-08-13 | Transdermal, oral and intravenous formulations of 2,3-dimethoxy-5-methyl-6-dacaprenyl-1,4-benzoquinone |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2159938T3 true ES2159938T3 (es) | 2001-10-16 |
Family
ID=25681130
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98908080T Expired - Lifetime ES2159938T3 (es) | 1997-02-11 | 1998-02-11 | Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona. |
Country Status (7)
Country | Link |
---|---|
US (1) | US20020155151A1 (es) |
EP (1) | EP1007021B1 (es) |
AT (1) | ATE201988T1 (es) |
CA (1) | CA2280316A1 (es) |
DE (1) | DE59800863D1 (es) |
ES (1) | ES2159938T3 (es) |
WO (1) | WO1998035660A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6878514B1 (en) | 1999-03-30 | 2005-04-12 | Purdue Research Foundation | Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
AU3930600A (en) * | 1999-03-30 | 2000-10-16 | Purdue Research Foundation | Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
JP4421801B2 (ja) * | 2000-05-09 | 2010-02-24 | 株式会社カネカ | 補酵素qを有効成分とする皮膚用組成物 |
TW200304372A (en) * | 2002-03-20 | 2003-10-01 | Kanegafuchi Chemical Ind | Compositions for diabetes |
WO2005034945A1 (fr) * | 2003-10-11 | 2005-04-21 | Thierry Schwitzguebel | Utilisation de la norphenazone et de coenzyme q pour le traitement de l'arthrose, l'arthrite et l'osteo-arthrite |
KR101535395B1 (ko) | 2004-01-22 | 2015-07-08 | 유니버시티 오브 마이애미 | 국소용 코-엔자임 큐10 제형 및 그의 사용 방법 |
CA2579710C (en) | 2004-04-05 | 2013-01-08 | The University Of Tokushima | Antigen-drug vehicle enabling transmucosal and transdermal administration, and method of inducing mucosal immunity and mucosal vaccine and dds using the same |
EP1930025B1 (en) * | 2005-08-05 | 2013-05-01 | The University of Tokushima | ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE |
CA2823407C (en) | 2007-03-22 | 2016-10-18 | Berg Pharma Llc | Topical formulations having enhanced bioavailability |
CA2721071C (en) | 2008-04-11 | 2017-10-17 | Cytotech Labs, Llc | Methods and use of inducing apoptosis in cancer cells |
EA201101519A1 (ru) | 2009-05-11 | 2012-10-30 | БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи | Способы диагностики метаболических нарушений, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния |
SG10202010355PA (en) * | 2010-03-12 | 2020-11-27 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
JP6092844B2 (ja) | 2011-04-04 | 2017-03-08 | バーグ エルエルシー | 中枢神経系腫瘍の治療方法 |
EP2720680B1 (en) | 2011-06-17 | 2020-02-12 | Berg LLC | Inhalable pharmaceutical compositions |
BR112015025424A2 (pt) | 2013-04-08 | 2017-07-18 | Berg Llc | tratamento de câncer usando terapias de combinação de coenzima q10 |
JP6595478B2 (ja) | 2013-09-04 | 2019-10-23 | バーグ エルエルシー | コエンザイムq10の連続注入によるがんの治療方法 |
CN107979996A (zh) * | 2015-04-30 | 2018-05-01 | 不莱梅大学 | 新的皮肤医疗和美容护理产品 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3073789A (en) * | 1988-03-31 | 1989-10-05 | Abbott Laboratories | Drug delivery using pulmonary surfactant to facilitate absorption |
US5006343A (en) * | 1988-12-29 | 1991-04-09 | Benson Bradley J | Pulmonary administration of pharmaceutically active substances |
ATE120366T1 (de) * | 1990-06-11 | 1995-04-15 | Idi Farmaceutici Spa | Aktive bestandteile enthaltende phospholipidische liposome und verfahren zu ihrer herstellung. |
DE4327063A1 (de) * | 1993-08-12 | 1995-02-16 | Kirsten Dr Westesen | Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften |
US5451569A (en) * | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
AU3705695A (en) * | 1994-10-26 | 1996-05-23 | Wellcome Foundation Limited, The | Pharmaceutical composition comprising atovaquone |
-
1998
- 1998-02-11 ES ES98908080T patent/ES2159938T3/es not_active Expired - Lifetime
- 1998-02-11 EP EP98908080A patent/EP1007021B1/de not_active Expired - Lifetime
- 1998-02-11 WO PCT/EP1998/000744 patent/WO1998035660A1/de active IP Right Grant
- 1998-02-11 US US09/355,931 patent/US20020155151A1/en not_active Abandoned
- 1998-02-11 AT AT98908080T patent/ATE201988T1/de active
- 1998-02-11 DE DE59800863T patent/DE59800863D1/de not_active Expired - Lifetime
-
1999
- 1999-08-13 CA CA002280316A patent/CA2280316A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1007021A1 (de) | 2000-06-14 |
CA2280316A1 (en) | 2001-02-13 |
EP1007021B1 (de) | 2001-06-13 |
ATE201988T1 (de) | 2001-06-15 |
DE59800863D1 (de) | 2001-07-19 |
WO1998035660A1 (de) | 1998-08-20 |
US20020155151A1 (en) | 2002-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2159938T3 (es) | Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona. | |
IL140710A0 (en) | Pulmonary delivery of active agents | |
ATE270557T1 (de) | Hochkonzentrierte, lyophilisierte und flüssige faktor-ix formulierungen | |
ZA200102105B (en) | Stable concentrated insulin preparations for pulmonary. | |
PT758248E (pt) | Formulacoes para o factor ix | |
NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
ATE554750T1 (de) | Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen | |
DK0812198T3 (da) | Stabilisering af prostaglandinpræparater | |
PL319603A1 (en) | Stable aqueous alpha interferon preparations | |
DK0830145T3 (da) | Formuleringer omfattende leflunomid | |
DE69708121T2 (de) | Halogenid-enthaltende insulinzubereitungen | |
ATE321534T1 (de) | Verbesserte liposomale formulierung | |
AU8332791A (en) | Oral pharmaceutical compositions containing melatonin | |
NO20001415L (no) | Farmasøytikum inneholdende vitamin-K-avhengige faktorer | |
ES2090966T3 (es) | Formulaciones liposomicas con piroxicam. | |
EP1269978A3 (de) | Verwendung von Bis-Resorcinyltriazinderivaten in kosmetischen oder dermatologischen Zubereitungen | |
ATE263576T1 (de) | Prostaglandine und benzylalcohol enthaltende lösung | |
ES2161041T3 (es) | Preparado de un tensioactivo pulmonar para instilacion y para la aplicacion oral. | |
IT8648748A0 (it) | Liposomi di coenzima q10.procedimento di preparazione e relative composizioni farmaceutiche |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 1007021 Country of ref document: ES |